sch 16134 has been researched along with Mental Disorders in 2 studies
quazepam: structure given in first source
Mental Disorders: Psychiatric illness or diseases manifested by breakdowns in the adaptational process expressed primarily as abnormalities of thought, feeling, and behavior producing either distress or impairment of function.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The mean number of insomnia complaints was significantly (p < ." | 2.67 | Evaluation of the safety and efficacy of quazepam for the treatment of insomnia in psychiatric outpatients. ( Mendels, J, 1994) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mendels, J | 1 |
| Wamsley, JK | 1 |
1 trial available for sch 16134 and Mental Disorders
| Article | Year |
|---|---|
Evaluation of the safety and efficacy of quazepam for the treatment of insomnia in psychiatric outpatients.
Topics: Adolescent; Adult; Ambulatory Care; Anti-Anxiety Agents; Antipsychotic Agents; Anxiety Disorders; Be | 1994 |
1 other study available for sch 16134 and Mental Disorders
| Article | Year |
|---|---|
GABA-benzodiazepine receptors.
Topics: Animals; Anti-Anxiety Agents; Benzodiazepines; Humans; Hypnotics and Sedatives; Mental Disorders; Py | 1992 |